ANIP logo

ANI Pharmaceuticals (ANIP) Return On Equity

Annual ROE

4.72%
+18.46%+134.35%

December 31, 2023

Summary

Performance

1-Year Change

+134.35%

3-Year Change

+142.75%

5-Year Change

-43.34%

15-Year Change

+861.29%

ANIP ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

73.81%
ANIP annual return on equity is higher than 73.81% of companies in Healthcare sector

High & Low

All-time High

31.81%
ANIP annual return on equity is currently -85.16% below its historical high of 31.81%

3-Year Low

-15.37%

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
ANIP previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 28, 2025
ANIP next annual earnings announcement is scheduled for Feb 28, 2025

OtherANIPprofitabilitymetrics:

Annual Revenue

$486.82 M
ANIP annual revenue is $486.82 million

Annual Net Income

$18.78 M
ANIP annual net profit is $18.78 million

Annual EPS

$0.85
ANIP annual earnings per share is $0.85

Annual ROA

2.26%
ANIP annual return on assets is 2.26%

Quarterly ROE

-1.54%
-7.40%-126.28%

September 30, 2024

Summary

Performance

3-Month Change

-126.28%

1-Year Change

-143.87%

3-Year Change

+80.13%

5-Year Change

-133.33%

ANIP Quarterly ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

69.97%
ANIP quarterly return on equity is higher than 69.97% of companies in Healthcare sector

High & Low

All-time High

41.21%
ANIP quarterly return on equity is currently -103.74% below its historical high of 41.21%

3-Year Low

-24.31%

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
ANIP previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
ANIP next earnings announcement is scheduled for Feb 28, 2025

OtherANIPprofitabilitymetrics:

Quarterly Revenue

$148.33 M
ANIP quarterly revenue is $148.33 million

Quarterly Net Income

-$24.17 M
ANIP quarterly net profit is -$24.17 million

Quarterly EPS

-$1.27
ANIP quarterly earnings per share is -$1.27

Quarterly ROA

-0.72%
ANIP quarterly return on assets is -0.72%

ROE Formula

ROE =  Net Income
Shareholders Equity ✕ 100%

Annual ROE

4.72%
ANIP annual return on equity is 4.72%

Annual Net Income

$18.78 M
ANIP annual net profit is $18.78 million

Annual Shareholders Equity

$457.60 M
ANIP annual stockholders equity is $457.60 million

ANIP ROE Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+134.3%-143.9%
3 y3 years+142.8%+80.1%
5 y5 years-43.3%-133.3%

ANIP ROE Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+130.7%-118.7%+93.7%
5 y5-yearat high+130.7%-118.7%+93.7%
alltimeall time-85.2%+101.5%-103.7%+99.6%

ANI Pharmaceuticals ROE History

DateAnnualQuarterly
Sep 2024
-
-1.54%(-126.3%)
Jun 2024
-
5.86%(-28.7%)
Mar 2024
-
8.22%(+77.2%)
Dec 2023
4.72%(-134.4%)
4.64%(+32.2%)
Sep 2023
-
3.51%(-343.8%)
Jun 2023
-
-1.44%(-81.4%)
Mar 2023
-
-7.75%(-44.4%)
Dec 2022
-13.74%(-10.6%)
-13.95%(-35.4%)
Sep 2022
-
-21.59%(-3.3%)
Jun 2022
-
-22.33%(-8.1%)
Mar 2022
-
-24.31%(+30.3%)
Dec 2021
-15.37%(+39.2%)
-18.66%(+65.1%)
Sep 2021
-
-11.30%(+28.3%)
Jun 2021
-
-8.81%(+12.5%)
Mar 2021
-
-7.83%(-30.8%)
Dec 2020
-11.04%(-471.7%)
-11.32%(-3.4%)
Sep 2020
-
-11.72%(+18.5%)
Jun 2020
-
-9.89%(+1398.5%)
Mar 2020
-
-0.66%(-122.3%)
Dec 2019
2.97%(-64.3%)
2.96%(-63.5%)
Sep 2019
-
8.10%(-9.1%)
Jun 2019
-
8.91%(+24.1%)
Mar 2019
-
7.18%(-13.9%)
Dec 2018
8.33%(-1443.5%)
8.34%(+3375.0%)
Sep 2018
-
0.24%(+242.9%)
Jun 2018
-
0.07%(+600.0%)
Mar 2018
-
0.01%(-101.6%)
Dec 2017
-0.62%(-125.9%)
-0.61%(-114.2%)
Sep 2017
-
4.29%(+37.9%)
Jun 2017
-
3.11%(+38.8%)
Mar 2017
-
2.24%(-6.3%)
Dec 2016
2.39%(-76.7%)
2.39%(-51.0%)
Sep 2016
-
4.88%(-22.2%)
Jun 2016
-
6.27%(-21.8%)
Mar 2016
-
8.02%(-21.8%)
Dec 2015
10.25%(-67.8%)
10.25%(-57.8%)
Sep 2015
-
24.30%(-14.9%)
Jun 2015
-
28.55%(+8.9%)
Mar 2015
-
26.21%(-15.4%)
Dec 2014
31.81%(+3556.3%)
30.98%(+100.1%)
Sep 2014
-
15.48%(+63.6%)
Jun 2014
-
9.46%(+28.7%)
Mar 2014
-
7.35%(-209.4%)
Dec 2013
0.87%(-101.0%)
-6.72%(-77.9%)
Sep 2013
-
-30.47%(-45.1%)
Jun 2013
-
-55.53%(-12.6%)
Mar 2013
-
-63.52%(-23.4%)
Dec 2012
-84.00%
-82.89%(-0.0%)
Sep 2012
-
-82.93%(-27.2%)
Jun 2012
-
-113.88%(-19.5%)
DateAnnualQuarterly
Mar 2012
-
-141.54%(-23.9%)
Dec 2011
-181.20%(-31.4%)
-185.94%(-25.7%)
Sep 2011
-
-250.42%(-13.4%)
Jun 2011
-
-289.07%(+20.4%)
Mar 2011
-
-240.01%(+3.8%)
Dec 2010
-264.15%(-17.6%)
-231.18%(-35.0%)
Sep 2010
-
-355.70%(-2.5%)
Jun 2010
-
-364.99%(-10.9%)
Mar 2010
-
-409.58%(-2.2%)
Dec 2009
-320.52%(+300.5%)
-418.65%(+190.3%)
Sep 2009
-
-144.23%(+15.4%)
Jun 2009
-
-124.96%(+20.0%)
Mar 2009
-
-104.15%(+25.9%)
Dec 2008
-80.02%(+152.1%)
-82.74%(+13.2%)
Sep 2008
-
-73.11%(+56.9%)
Jun 2008
-
-46.59%(+34.8%)
Mar 2008
-
-34.57%(+16.8%)
Dec 2007
-31.74%(-241.5%)
-29.59%(-306.5%)
Sep 2007
-
14.33%(-43.9%)
Jun 2007
-
25.54%(-38.0%)
Mar 2007
-
41.21%(+21.6%)
Dec 2006
22.43%(-126.4%)
33.88%(-125.3%)
Sep 2006
-
-133.83%(-6.1%)
Jun 2006
-
-142.54%(+27.0%)
Mar 2006
-
-112.26%(+30.9%)
Dec 2005
-84.88%(-13.1%)
-85.78%(+4.7%)
Sep 2005
-
-81.92%(+9.0%)
Jun 2005
-
-75.15%(-4.1%)
Mar 2005
-
-78.36%(-3.4%)
Dec 2004
-97.67%(+9.1%)
-81.15%(+16.1%)
Sep 2004
-
-69.89%(-12.9%)
Jun 2004
-
-80.22%(-28.7%)
Mar 2004
-
-112.56%(+9.2%)
Dec 2003
-89.56%(+1.9%)
-103.09%(+10.8%)
Sep 2003
-
-93.08%(-24.5%)
Jun 2003
-
-123.31%(+8.8%)
Mar 2003
-
-113.29%(+7.7%)
Dec 2002
-87.85%(+3.9%)
-105.17%(-17.1%)
Sep 2002
-
-126.90%(+25.7%)
Jun 2002
-
-100.92%(+44.0%)
Mar 2002
-
-70.10%(+11.4%)
Dec 2001
-84.55%(-6.8%)
-62.92%(+16.8%)
Sep 2001
-
-53.89%(-37.9%)
Jun 2001
-
-86.73%(-12.2%)
Mar 2001
-
-98.77%(-1.3%)
Dec 2000
-90.74%(+160.7%)
-100.05%(+54.3%)
Sep 2000
-
-64.84%(+47.3%)
Jun 2000
-
-44.01%(+199.6%)
Mar 2000
-
-14.69%
Dec 1999
-34.80%(-65.6%)
-
Dec 1998
-101.06%
-

FAQ

  • What is ANI Pharmaceuticals annual return on equity?
  • What is the all time high annual ROE for ANI Pharmaceuticals?
  • What is ANI Pharmaceuticals annual ROE year-on-year change?
  • What is ANI Pharmaceuticals quarterly return on equity?
  • What is the all time high quarterly ROE for ANI Pharmaceuticals?
  • What is ANI Pharmaceuticals quarterly ROE year-on-year change?

What is ANI Pharmaceuticals annual return on equity?

The current annual ROE of ANIP is 4.72%

What is the all time high annual ROE for ANI Pharmaceuticals?

ANI Pharmaceuticals all-time high annual return on equity is 31.81%

What is ANI Pharmaceuticals annual ROE year-on-year change?

Over the past year, ANIP annual return on equity has changed by +18.46% (+134.35%)

What is ANI Pharmaceuticals quarterly return on equity?

The current quarterly ROE of ANIP is -1.54%

What is the all time high quarterly ROE for ANI Pharmaceuticals?

ANI Pharmaceuticals all-time high quarterly return on equity is 41.21%

What is ANI Pharmaceuticals quarterly ROE year-on-year change?

Over the past year, ANIP quarterly return on equity has changed by -5.05% (-143.87%)